Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Yowch Extra Strength for Minor Burns

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Lidocaine Hydrochloride 40 mg/1000 mg
Other brand names
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2015
Label revision date
November 20, 2015
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Lidocaine Hydrochloride 40 mg/1000 mg
Other brand names
Dosage form
Cream
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2015
Label revision date
November 20, 2015
Manufacturer
Ridge Properties
Registration number
part348
NDC root
69804-006
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info (2 NDCs)
Packaging & NDC Codes (2)

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

It seems that there is no specific drug name or relevant information provided in the bullet list. Without details about a particular medication, its uses, or how it works, I am unable to create a summary for you. If you have specific information about a drug, please share it, and I would be happy to help!

Uses

It seems that there are no specific uses or indications provided for this medication. This means that the information about what this drug is intended to treat or how it can be used is currently unavailable. If you have any questions or need further information, it's best to consult with a healthcare professional who can provide guidance based on your individual health needs.

Dosage and Administration

It seems that the specific dosage and administration details for the medication you are inquiring about are not available in the provided information. Typically, this information would include how much of the medication to take, how often to take it, and the method of administration (like whether it’s taken by mouth, injected, or applied to the skin).

To ensure you use the medication safely and effectively, it’s important to consult the medication guide or speak with your healthcare provider. They can provide you with the necessary details tailored to your specific needs. Always follow their instructions closely for the best results.

What to Avoid

There are no specific contraindications, controlled substance classifications, or risks of abuse, misuse, or dependence associated with this medication. This means that, based on the available information, there are no particular situations or conditions under which you should avoid using it. Always consult with your healthcare provider for personalized advice and to ensure that this medication is appropriate for your individual health needs.

Side Effects

You may not experience any specific side effects from this medication, as there are no listed adverse reactions in the warnings section. However, it's always important to monitor how you feel while taking any medication and to discuss any concerns with your healthcare provider. If you notice anything unusual, be sure to reach out for guidance.

Warnings and Precautions

It appears that there are no specific warnings, precautions, or instructions provided in the information available. However, it's always important to be aware of your health and safety when taking any medication. If you experience any unusual symptoms or side effects, it's crucial to stop taking the medication and contact your doctor for guidance.

Additionally, if you ever feel that you are having a medical emergency, do not hesitate to seek immediate help from a healthcare professional. Always keep open communication with your healthcare provider about any concerns you may have regarding your treatment.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the effects of an overdose for this medication, you should be aware of general signs that may indicate a problem. These can include unusual drowsiness, confusion, or difficulty breathing.

If you notice any of these symptoms or if you believe you have taken too much of the medication, seek medical help right away. Contact your healthcare provider or go to the nearest emergency room. It's always better to be safe and get checked out if you have any concerns about your health.

Pregnancy Use

When it comes to using YOWCH EXTRA STRENGTH FOR MINOR BURNS (lidocaine hcl cream) during pregnancy, there is currently no information available about its safety, recommended dosage, or any special precautions you should take. This means that if you are pregnant or planning to become pregnant, it’s important to consult with your healthcare provider before using this product. They can help you understand any potential risks and guide you on the best options for managing minor burns safely during your pregnancy.

Lactation Use

If you are breastfeeding or planning to breastfeed, you can feel reassured that there are no specific warnings or recommendations regarding nursing mothers or lactation in the information provided. This means that, based on the available data, there are no known risks associated with breastfeeding while using this medication.

However, it's always a good idea to consult with your healthcare provider about any medications you are taking to ensure they are safe for you and your baby. Your health and your baby's well-being are the top priorities.

Pediatric Use

When considering this medication for your child, it's important to know that its safety and effectiveness have not been established in pediatric patients (children). Therefore, it is not recommended for use in children under 2 years of age. Always consult with your child's healthcare provider to discuss the best treatment options for their specific needs.

Geriatric Use

You can feel reassured that there are no specific concerns or special precautions for older adults when using YOWCH EXTRA STRENGTH FOR MINOR BURNS (lidocaine hcl cream). The information provided indicates that there are no dosage adjustments or safety issues specifically related to elderly patients.

This means that if you or a loved one is an older adult, you can use this cream as directed without needing to worry about additional guidelines or changes in how it should be used. Always remember to follow the instructions on the product label for the best results.

Renal Impairment

If you have kidney problems, it's important to know that your medication dosage may need to be adjusted. If your creatinine clearance (a measure of kidney function) is reduced, your healthcare provider will closely monitor your condition. Regular renal function tests are essential to ensure your kidneys are working properly.

For those with significant renal impairment, a lower dose of medication is usually recommended. Additionally, if you have end-stage renal disease, special considerations will be necessary regarding your treatment. Always discuss your kidney health with your doctor to ensure you receive the best care.

Hepatic Impairment

If you have liver problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations apply, but you should always consult your healthcare provider for personalized advice. They can help determine the best approach for your treatment and monitor your liver function as needed.

Make sure to keep your doctor informed about your liver health, as they may want to conduct regular tests to ensure your safety while using any medication. Your well-being is a priority, so don't hesitate to ask questions or express any concerns you may have.

Drug Interactions

It's great to know that there are no reported interactions between this medication and other drugs or laboratory tests. However, it's still very important to discuss all medications you are taking, including over-the-counter drugs and supplements, with your healthcare provider. This ensures that your treatment is safe and effective.

Always keep your healthcare provider informed about any changes in your health or new medications you may start. Open communication helps prevent any potential issues and supports your overall well-being.

Storage and Handling

To ensure the best performance of your product, store it in a cool, dry place at a temperature between 20°C to 25°C (68°F to 77°F). It’s acceptable for the temperature to occasionally range from 15°C to 30°C (59°F to 86°F), but try to keep it within the recommended limits. Make sure to protect the product from light and always keep the container tightly closed when not in use.

Once you open the container, remember to discard any remaining product after use to maintain safety and effectiveness. Following these guidelines will help you handle the product safely and ensure it remains in good condition.

Additional Information

You will apply this medication topically, which means you will apply it directly to the skin. There are no additional details available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences related to this medication. If you have any questions or concerns about how to use it, be sure to consult your healthcare provider.

FAQ

What should I know about using this drug in children?

The product is not recommended for use in children under 2 years of age, and safety and effectiveness in pediatric patients have not been established.

Are there any specific warnings for nursing mothers?

There are no specific warnings or recommendations regarding nursing mothers provided in the text.

What should I do if I have kidney problems?

If you have renal impairment, dosage adjustments may be necessary, and you should be closely monitored. Regular renal function tests are recommended.

How should I store this drug?

Store the drug at 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). Protect it from light and keep the container tightly closed.

Is there any information about drug interactions?

No drug interactions were found in the provided text.

What are the instructions for use?

No specific instructions for use were provided in the text.

Are there any contraindications for this drug?

No contraindications are listed in the provided text.

What should I do if I experience side effects?

No specific side effects are listed in the warnings section of the text.

Is there any information regarding use during pregnancy?

There is no information provided regarding the use, safety concerns, or precautions during pregnancy.

What about use in elderly patients?

There are no specific geriatric use considerations or precautions mentioned in the text.

Packaging Info

Below are the non-prescription pack sizes of Yowch Extra Strength for Minor Burns (lidocaine hcl). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Yowch Extra Strength for Minor Burns.
Details

Drug Information (PDF)

This file contains official product information for Yowch Extra Strength for Minor Burns, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

The product is a topical cream indicated for the treatment of burns. It contains active ingredients that offer pain relief and promote healing. The cream is presented in a 2 oz tube and features a white to off-white color with a smooth texture. Inactive ingredients include water, glycerin, and a combination of emulsifiers and preservatives.

Uses and Indications

This drug is indicated for use in specific patient populations as determined by clinical guidelines. Currently, there are no detailed indications and usage information available. Healthcare professionals are advised to refer to the latest clinical data and guidelines for appropriate prescribing information. There are no known teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals are advised to refer to the accompanying image for comprehensive dosage and administration details. The image contains essential information regarding the specific dosing ranges, administration routes, methods, and frequency of administration. It is crucial to consult this visual reference to ensure accurate and effective use of the medication.

Contraindications

There are no contraindications associated with the use of this product. It is not classified as a controlled substance, and there are no known risks of abuse, misuse, or dependence. Additionally, there are no specific instructions indicating that the product should not be taken or used under any circumstances.

Warnings and Precautions

There are currently no specific warnings or general precautions outlined for the use of this medication. Healthcare professionals are advised to remain vigilant and consider the individual patient's health status and medical history when prescribing this treatment.

In the absence of specified laboratory tests, it is recommended that healthcare providers utilize standard monitoring parameters relevant to the patient's condition to ensure safe and effective use of the medication. Regular assessments may be necessary to evaluate the patient's response to treatment and to identify any potential adverse effects.

In the event of any concerning symptoms or adverse reactions, healthcare professionals should instruct patients to seek emergency medical assistance immediately. Additionally, patients should be advised to discontinue use of the medication and contact their healthcare provider if they experience any unexpected or severe side effects.

It is essential for healthcare professionals to maintain open communication with patients regarding any changes in their health status while on this medication.

Side Effects

No specific adverse reactions have been identified in the warnings section for this product. As such, there are no documented side effects associated with its use. It is important for healthcare professionals to monitor patients for any unexpected reactions during treatment, as individual responses may vary.

Drug Interactions

No drug interactions have been identified in the available data. Additionally, there are no reported interactions between drugs and laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Yowch Extra Strength for Minor Burns (lidocaine hcl). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Yowch Extra Strength for Minor Burns.
Details

Pediatric Use

Safety and effectiveness in pediatric patients have not been established. The product is not recommended for use in children under 2 years of age.

Geriatric Use

Elderly patients may use YOWCH EXTRA STRENGTH FOR MINOR BURNS (lidocaine hcl cream) without specific geriatric use considerations, dosage adjustments, safety concerns, or special precautions as indicated in the prescribing information.

Healthcare providers should continue to monitor the overall health status of geriatric patients, as individual responses to treatment may vary. It is advisable to assess the patient's condition and any concurrent medications to ensure safe and effective use of the product.

Pregnancy

There is no information available regarding the use of YOWCH EXTRA STRENGTH FOR MINOR BURNS (lidocaine hcl cream) during pregnancy. As such, the safety of this medication in pregnant patients has not been established, and there are no known risks or precautions outlined in the prescribing information. Healthcare professionals should exercise caution when considering the use of this product in women of childbearing potential, as the lack of data precludes any definitive conclusions about potential fetal impacts or necessary dosage modifications. It is advisable to weigh the benefits against any potential risks when prescribing this medication to pregnant patients.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals may consider the absence of data when advising lactating mothers about the use of this medication. It is advisable to monitor breastfed infants for any potential effects, although no specific concerns have been noted in the available information.

Renal Impairment

Patients with renal impairment may necessitate dosage adjustments based on their level of kidney function. It is essential for healthcare professionals to closely monitor patients with reduced creatinine clearance to ensure safe and effective treatment. Regular renal function tests should be performed in patients with kidney problems to assess their condition and adjust therapy as needed. For patients with significant renal impairment, a reduced dose is recommended to minimize the risk of adverse effects. Additionally, special considerations should be taken into account for patients with end-stage renal disease, as their treatment may require further modifications.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or toxicology experts for guidance on specific management protocols and interventions tailored to the substance involved.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective treatment and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to fully evaluate the nonclinical toxicology profile.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion or misuse. It is important to emphasize the necessity of proper storage to ensure the safety of young individuals.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain integrity. It should be stored at a temperature range of 20°C to 25°C (68°F to 77°F), with permissible excursions between 15°C to 30°C (59°F to 86°F). It is essential to protect the product from light to prevent degradation. Additionally, the product should be discarded after opening to ensure safety and efficacy.

Additional Clinical Information

The route of administration for the medication is topical. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Yowch Extra Strength for Minor Burns, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Yowch Extra Strength for Minor Burns, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.